ロード中...
Dipeptide Prodrugs of the Glutamate Modulator Riluzole
[Image: see text] We have previously reported a prodrug strategy based on the marketed drug riluzole (2-amino-6-trifluoromethoxybenzothiazole), associated with the benefits of lower patient to patient variability of exposure and potentially once daily oral dosing, as opposed to the large variance an...
保存先:
| 出版年: | ACS Med Chem Lett |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Chemical
Society
2018
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047042/ https://ncbi.nlm.nih.gov/pubmed/30034613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00189 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|